Periarticular Versus Intravenous Corticosteroids in Total Knee Arthroplasty: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Document Type : SYSTEMATIC REVIEW

Authors

1 Department of Orthopaedic Surgery, Lebanese University, Beirut, Lebanon

2 Department of Orthopaedic Surgery, Warren Alpert Medical School of Brown University, Providence, RI, USA

10.22038/abjs.2025.84324.3834

Abstract

Objectives: Despite the extensive research revolving around total knee arthroplasty (TKA), the optimal steroid administration route remains unclear. This study aimed to compare the clinical efficacy of intravenous (IV) to periarticular (PA) steroid administration in TKA.
Methods: Embase, PubMed, Cochrane, and Google Scholar were searched till April 2024 for randomized controlled trials (RCT) comparing IV to PA steroids in TKA. Each trial was assessed using the Cochrane risk-of-bias tool and classified as having a High, Low, or Unclear risk of bias. The clinical outcomes of interest were post-operative pain (reported as the Visual Analogue Scale (VAS) and Numeric Rating Scale (NRS)), vomiting, post-operative range of motion (reported as knee flexion angle), post-operative IL-6 and CRP, and glucose levels. Post-operative complications such as surgical site or deep infections, and wound dehiscence following TKA were also recorded and assessed.
Results: Five RCTs with a total of 501 patients were included in this review.  There were no significant differences in pain at rest on post-operative day (POD) 1 and 2 and during activity between PA and IV administration, while pain at rest on POD 3 was lower in the PA group (I2 =38% SMD=-0.27; 95% CI: -0.5, -0.04, P=0.02). Post-operative complications, knee flexion, and laboratory values such as IL-6, CPR, and glucose showed no significant difference between the groups, while vomiting rates were significantly higher in the PA group (I2= 0% OR=2.43; 95% CI: 1.36–4.35, P=0.003).
Conclusion: PA and IV peri-operative administration of glucocorticoids in TKA have similar clinical outcomes in inflammation reduction, knee flexion function, adverse event rates, and post-operative pain at rest during the first 48 hours post-operatively and at activity, while the PA group is associated with lower pain at rest on POD 3 and a higher rate of post-operative vomiting.
        Level of evidence: II

Keywords

Main Subjects

References

  1. Hsu H, Siwiec RM, eds. Knee Arthroplasty. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.
  2. Steinhaus ME, Christ AB, Cross MB. Total Knee Arthroplasty for Knee Osteoarthritis: Support for a Foregone Conclusion? HSS J. 2017; 13(2):207-210. doi:10.1007/s11420-017-9558-4.
  3. Hartman J, Khanna V, Habib A, Farrokhyar F, Memon M, Adili A. Perioperative systemic glucocorticoids in total hip and knee arthroplasty: A systematic review of outcomes. J Orthop. 2017; 14(2):294-301. doi: 10.1016/j.jor.2017.03.012.
  4. Zhuo Y, Yu R, Wu C, Huang Y, Ye J, Zhang Y. The role of perioperative intravenous low-dose dexamethasone in rapid recovery after total knee arthroplasty: a meta-analysis. J Int Med Res. 2021; 49(3):300060521998220. doi:10.1177/0300060521998220.
  5. Wang Y, Yang Q, Lin J, et al. Risk factors of postoperative nausea and vomiting after total hip arthroplasty or total knee arthroplasty: a retrospective study. Ann Transl Med. 2020; 8(17):1088. doi:10.21037/atm-20-5486.
  6. Peersman G, Laskin R, Davis J, Peterson M. Infection in Total Knee Replacement: A Retrospective Review of 6489 Total Knee Replacements. Clin Orthop Relat Res. 2001:(392):15-23.
  7. Zhang J, Huang J xun. Administration with corticosteroid relieving pain following total knee arthroplasty: A meta-analysis. Medicine (Baltimore). 2020; 99(51):e23567. doi: 10.1097/MD.0000000000023567.
  8. McCartney CJL, Nelligan K. Postoperative Pain Management after Total Knee Arthroplasty in Elderly Patients: Treatment Options. Drugs Aging. 2014; 31(2):83-91. doi:10.1007/s40266-013-0148-y.
  9. Wu Y, Lu X, Ma Y, et al. Perioperative multiple low-dose Dexamethasones improves postoperative clinical outcomes after Total knee arthroplasty. BMC Musculoskelet Disord. 2018; 19(1):428. doi: 10.1186/s12891-018-2359-1.
  10. Si HB, Yang TM, Zeng Y, et al. Correlations between inflammatory cytokines, muscle damage markers and acute postoperative pain following primary total knee arthroplasty. BMC Musculoskelet Disord. 2017; 18(1):265. doi:10.1186/s12891-017-1597-y.
  11. Hall GM, Peerbhoy D, Shenkin A, Parker CJ, Salmon P. Relationship of the functional recovery after hip arthroplasty to the neuroendocrine and inflammatory responses. Br J Anaesth. 2001; 87(4):537-542. doi:10.1093/bja/87.4.537.
  12. Changjun C, Jingkun L, Yun Y, et al. Enhanced Recovery after Total Joint Arthroplasty (TJA): A Contemporary Systematic Review of Clinical Outcomes and Usage of Key Elements. Orthop Surg. 2023;15(5):1228-1240. doi:10.1111/os.13710
  13. Ms YM, Ms ME, Kuzuya T, Osada T, Ishiguro N. Methylprednisolone reduces postoperative nausea in total knee and hip arthroplasty. J Clin Pharm Ther. 2010; 35(6):679-84. doi: 10.1111/j.1365-2710.2009.01141.x.
  14. Xu B, Ma J, Huang Q, Huang Z yu, Zhang S yun, Pei F xing. Two doses of low-dose perioperative dexamethasone improve the clinical outcome after total knee arthroplasty: a randomized controlled study. Knee Surg Sports Traumatol Arthrosc. 2018; 26(5):1549-1556. doi:10.1007/s00167-017-4506-x.
  15. Zhou G, Ma L, Jing J, Jiang H. A meta-analysis of dexamethasone for pain management in patients with total knee arthroplasty. Medicine (Baltimore). 2018; 97(35):e11753. doi: 10.1097/MD.0000000000011753.
  16. Fan Z, Ma J, Kuang M, et al. The efficacy of dexamethasone reducing postoperative pain and emesis after total knee arthroplasty: A systematic review and meta-analysis. Int J Surg. Int J Surg. 2018:52:149-155. doi: 10.1016/j.ijsu.2018.02.043.
  17. Hannon CP, Fillingham YA, Mason JB, et al. The Efficacy and Safety of Corticosteroids in Total Joint Arthroplasty: A Direct Meta-Analysis. J Arthroplasty. 2022; 37(10):1898-1905.e7. doi:https://doi.org/10.1016/j.arth.2022.03.084.
  18. Tammachote N, Kanitnate S. Intravenous Dexamethasone Injection Reduces Pain from 12 to 21 Hours after Total Knee Arthroplasty: A Double-Blind, Randomized, Placebo-Controlled Trial. J Arthroplasty. 2020; 35(2):394-400. doi:10.1016/j.arth.2019.09.002.
  19. Backes JR, Bentley JC, Politi JR, Chambers BT. Dexamethasone reduces length of hospitalization and improves postoperative pain and nausea after total joint arthroplasty: a prospective, randomized controlled trial. J Arthroplasty. 2013; 28(8 Suppl):11-17. doi:10.1016/j.arth.2013.05.041.
  20. Xing LZ, Li L, Zhang LJ. Can intravenous steroid administration reduce postoperative pain scores following total knee arthroplasty?: A meta-analysis. Medicine (Baltimore). 2017; 96(24):e7134. doi: 10.1097/MD.0000000000007134.
  21. Sculco P, Mclawhorn A, Desai N, Su E, Padgett D, Jules-elysee K. AC. J Arthroplasty. 2016; 31(6):1208-1212.. doi:10.1016/j.arth.2015.11.011.
  22. Li D, Zhao J, Yang Z, Kang P, Shen B, Pei F. Multiple Low Doses of Intravenous Corticosteroids to Improve Early Rehabilitation in Total Knee Arthroplasty: A Randomized Clinical Trial. J Knee Surg. 2019; 32(2):171-179. doi:10.1055/s-0038-1636506.
  23. Ikeuchi M, Kamimoto Y, Izumi M, et al. Effects of dexamethasone on local infiltration analgesia in total knee arthroplasty: a randomized controlled trial. Knee Surg Sports Traumatol Arthrosc. 2014; 22(7):1638-1643. doi:10.1007/s00167-013-2367-5.
  24. Kurosaka K, Tsukada S, Ogawa H, Nishino M, Yoshiya S, Hirasawa N. Comparison of Early-Stage and Late-Stage Periarticular Injection for Pain Relief After Total Hip Arthroplasty: A Double-Blind Randomized Controlled Trial. J Arthroplasty. 2020; 35(5):1275-1280. doi:10.1016/j.arth.2019.12.020.
  25. Li Q, Mu G, Liu X, Chen M. Efficacy of additional corticosteroids to multimodal cocktail periarticular injection in total knee arthroplasty: a meta-analysis of randomized controlled trials. J Orthop Surg Res. 2021; 16(1):77. doi:10.1186/s13018-020-02144-0.
  26. Tsukada S, Wakui M, Hoshino A. The impact of including corticosteroid in a periarticular injection for pain control after total knee arthroplasty: a double-blind randomised controlled trial. Bone Joint J. 2016; 98-B (2):194-200. doi:10.1302/0301-620X.98B2.36596.
  27. Li D, Wang Q, Zhao X, Luo Y, Kang P. Comparison of Intravenous and Topical Dexamethasone for Total Knee Arthroplasty: A Randomized Double-Blinded Controlled Study of Effects on Dexamethasone Administration Route and Enhanced Recovery. J Arthroplasty. 2021; 36(5):1599-1606. doi:10.1016/j.arth.2020.11.019.
  28. Chan PK, Chan TCW, Mak CYH, et al. Pain Relief after Total Knee Arthroplasty with Intravenous and Periarticular Corticosteroid: A Randomized Controlled Trial. J Bone Jt Surg. 2023; 105(12):924-932. doi:10.2106/JBJS.22.01218.
  29. Li Q, Fang G, Liao W, et al. Intraoperative intravenous versus periarticular injection of glucocorticoids in improving clinical outcomes after total knee arthroplasty: A prospective, randomized and controlled study. J Orthop Surg. 2024; 32(2):1-9. doi:10.1177/10225536241256554.
  30. Saini MK, Reddy NR, Reddy PJ, Thakur AS, Reddy CD. The application of low-dose dexamethasone in total knee arthroplasty: finding out the best route and dosage schedule. Arch Orthop Trauma Surg. 2023; 143(2):1005-1012. doi:10.1007/s00402-022-04356-x.
  31. Hatayama K, Terauchi M, Oshima A, Kakiage H, Ikeda K, Higuchi H. Comparison of intravenous and periarticular administration of corticosteroids in total knee arthroplasty: a prospective, randomized controlled study. J Bone Joint Surg Am. 2021; 103(4):319-325. doi: 10.2106/JBJS.20.01153.
  32. Higgins JPT, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011:343:d5928. doi: 10.1136/bmj.d5928.
  33. Singh JA, Lemay CA, Nobel L, et al. Association of Early Postoperative Pain Trajectories with Longer-term Pain Outcome after Primary Total Knee Arthroplasty. JAMA Netw Open. 2019; 2(11):e1915105-e1915105. doi:10.1001/jamanetworkopen.2019.15105.
  34. Lo LWT, Suh J, Chen JY, et al. Early Postoperative Pain After Total Knee Arthroplasty Is Associated With Subsequent Poorer Functional Outcomes and Lower Satisfaction. J Arthroplasty. 2021; 36(7):2466-2472. doi: 10.1016/j.arth.2021.02.044.
  35. Schindler M, Schmitz S, Reinhard J, Jansen P, Grifka J, Benditz A. Pain Course after Total Knee Arthroplasty within a Standardized Pain Management Concept: A Prospective Observational Study. J Clin Med. 2022; 11(23). doi:10.3390/jcm11237204.
  36. Holte K, Kehlet H. Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications. J Am Coll Surg. 2002; 195(5):694-712.

 

       doi:10.1016/s1072-7515(02)01491-6.

  1. Ugraş AA, Kural C, Kural A, Demirez F, Koldaş M, Çetinus E. Which is more important after total knee arthroplasty: Local inflammatory response or systemic inflammatory response? Knee. 2011; 18(2):113-116. doi: 10.1016/j.knee.2010.03.004.
  2. Shah N. Increasing knee range of motion using a unique sustained method. N Am J Sports Phys Ther. 2008; 3(2):110-113.
  3. Han HS, Kim JS, Lee B, Won S, Lee MC. A high degree of knee flexion after TKA promotes the ability to perform high-flexion activities and patient satisfaction in Asian population. BMC Musculoskelet Disord. 2021; 22(1):565. doi:10.1186/s12891-021-04369-4.
  4. Oka T, Wada O, Asai T, Maruno H, Mizuno K. Importance of knee flexion range of motion during the acute phase after total knee arthroplasty. Phys Ther Res. 2020; 23(2):143-148. doi:10.1298/ptr.E9996.
  5. Keohane D, Sheridan G, Harty J. Perioperative steroid administration improves knee function and reduces opioid consumption in bilateral total knee arthroplasty. J Orthop. 2020; 22:449-453. doi:10.1016/j.jor.2020.10.004.
  6. Jules-Elysee KM, Lipnitsky JY, Patel N, et al. Use of low-dose steroids in decreasing cytokine release during bilateral total knee replacement. Reg Anesth Pain Med. 2011; 36(1):36-40. doi:10.1097/AAP.0b013e31820306c5.
  7. Habib G. Systemic effects of intra-articular corticosteroids. Clin Rheumatol. 2009; 28:749-756. doi:10.1007/s10067-009-1135-x.
  8. Kishimoto T. The biology of interleukin-6. Blood. 1989; 74(1):1-10.
  9. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 2011; 1813(5):878-888. doi:10.1016/j.bbamcr.2011.01.034.
  10. Honsawek S, Deepaisarnsakul B, Tanavalee A, et al. Relationship of serum IL-6, C-reactive protein, erythrocyte sedimentation rate, and knee skin temperature after total knee arthroplasty: a prospective study. Int Orthop. 2011; 35(1):31-35. doi:10.1007/s00264-010-0973-0.
  11. Chen X, Bai C, Xie L, Zhang Y, Wang K. Inflammatory response to orthopedic biomaterials after total hip replacement. J Orthop Sci.2012; 17(4):407-412. doi:10.1007/s00776-012-0234-8.
  12. Takeshita M, Nakamura J, Ohtori S, et al. Sensory innervation and inflammatory cytokines in hypertrophic synovia associated with pain transmission in osteoarthritis of the hip: a case-control study. Rheumatology (Oxford). 2012; 51(10):1790-1795. doi:10.1093/rheumatology/kes173.
  13. Watkins LR, Maier SF, Goehler LE. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain. 1995; 63(3):289-302. doi:10.1016/0304-3959(95)00186-7.
  14. Rytter S, Stilling M, Munk S, Hansen TB. Methylprednisolone reduces pain and decreases knee swelling in the first 24 h after fast-track unicompartmental knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2017; 25(1):284-290. doi:10.1007/s00167-014-3501-8.
  15. Smith C, Erasmus PJ, Myburgh KH. Endocrine and Immune Effects of Dexamethasone in Unilateral Total Knee Replacement. J Int Med Res. 2006; 34(6):603-611. doi:10.1177/147323000603400605.
  16. Wang SH, Xu C, Tan TL, Goswami K, Cooper AM, Parvizi J. Increased Postoperative Glucose Variability Is Associated With Adverse Outcome Following Two-Stage Exchange Arthroplasty for Periprosthetic Joint Infection. J Arthroplasty. 2020; 35(5):1368-1373. doi:10.1016/j.arth.2019.11.046.
  17. Godshaw BM, Mehl AE, Shaffer JG, Meyer MS, Thomas LC, Chimento GF. The Effects of Peri-Operative Dexamethasone on Patients Undergoing Total Hip or Knee Arthroplasty: Is It Safe for Diabetics? J Arthroplasty. 2019; 34(4):645-649. doi:10.1016/j.arth.2018.12.014.
  18. Roberts A, James J, Dhatariya K, et al. Management of hyperglycaemia and steroid (glucocorticoid) therapy: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group. Diabet Med. 2018; 35(8):1011-1017. doi:https://doi.org/10.1111/dme.13675.
  19. Sauerland S, Nagelschmidt M, Mallmann P, Neugebauer EA. Risks and benefits of preoperative high dose methylprednisolone in surgical patients: a systematic review. Drug Saf. 2000; 23(5):449-461. doi:10.2165/00002018-200023050-00007.
  20. Salerno A, Hermann R. Efficacy and safety of steroid use for postoperative pain relief. Update and review of the medical literature. J Bone Joint Surg Am. 2006; 88(6):1361-1372. doi:10.2106/JBJS.D.03018.
  21. Jørgensen CC, Pitter FT, Kehlet H. Safety aspects of preoperative high-dose glucocorticoid in primary total knee replacement. Br J Anaesth. 2017; 119(2):267-275. doi:10.1093/bja/aex190.
  22. Tramèr MR. A rational approach to the control of postoperative nausea and vomiting: evidence from systematic reviews. Part I. Efficacy and harm of antiemetic interventions, and methodological issues. Acta Anaesthesiol Scand. 2001; 45(1):4-13. doi: 10.1034/j.1399-6576.2001.450102.x.
  23. Hirsch J. Impact of postoperative nausea and vomiting in the surgical setting. Anaesthesia. 1994; 49(1):30-33. doi:10.1111/j.1365-2044.1994.tb03580.x.
  24. Rodríguez-Merchán EC. Outpatient total knee arthroplasty: is it worth considering? EFORT open Rev. 2020; 5(3):172-179. doi:10.1302/2058-5241.5.180101.

 

 

 

 

The Archives of Bone and Joint Surgery
Volume 13, Issue 5
May 2025
Pages 237-248

Files

History

  • Receive Date: 27 November 2024
  • Revise Date: 12 January 2025
  • Accept Date: 15 January 2025

Share

How to cite

Statistics